159448-57-4Relevant articles and documents
THIAZOLIDINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS
-
Page/Page column 33, (2011/05/08)
The invention relates to thiazolidine derivatives of the formula (I) wherein A, B, and R1 are as described in the description, to salts, especially pharmaceutically acceptable salts, of such compounds and to their use as medicaments, especially
THIAZOLIDINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS
-
Page/Page column 66, (2010/04/03)
The invention relates to thiazolidine derivatives of the formula (I) wherein A, B, and R1 are as described in the description, to salts, especially pharmaceutically acceptable salts, of such compounds and to their use as medicaments, especially
Imidazole ethers having a II antagonist activity
-
, (2008/06/13)
Compounds of general formula (I) STR1 wherein E is O or S; R is C 1 -C 5 straight, branched or cyclic alkyl or C 2 -C 5 alkenyl; X can be H, F, Cl, Br, I, CF 3 ; n is an integer 1 to 4; m is an integer 0 to 4; A and B are 5- or 6- membered aromatic carboc
Nonpeptide Angiotensin II Receptor Antagonists. Synthesis, in Vitro Activity, and Molecular Modeling Studies of N-imidazoles
Salimbeni, Aldo,Canevotti, Renato,Paleari, Fabio,Bonaccorsi, Fabrizio,Renzetti, Anna R.,et al.
, p. 3928 - 3938 (2007/10/02)
With the aim of explaining the influence of the structural changes on the biphenylic moiety on the activity, a series of N-imidazoles (I), constructed on the model of DuPont compounds by replacing either the central or terminal pheny